News

Deal Announcements

Ablative Solutions Secures Venture Capital Funds

Thursday, October 23, 2014 5:32:00 AM PDT | VentureDeal
   Kalamazoo, Michigan  --  Medical device technology company Ablative Solutions has received $4.7 million in new venture capital equity funding, according to an SEC regulatory filing.

Ablative has developed endovascular catheter technology as an alternative to surgical renal innervation for the treatment of hypertension and other diseases.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Ablative is still seeking $3.2 million in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1